Here's a clue.
Janine Small, Pfizer’s president of international developed markets, was testifying before the European Union Parliament.
Apparently not if you move at the speed of science !
All well and good, those patients have given their (informed) consent acknowledging the drug may have no positive effect or in fact be harmful.